Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
about
Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasiaNeuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinaseA natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxisNeuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytesAnalysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasionEpidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptorsThe metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF)N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivoThe role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygiumHeparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesisAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneNMDA receptor agonists reverse impaired psychomotor and cognitive functions associated with hippocampal Hbegf-deficiency in miceHeparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice.Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesisExpression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour typesHeparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen-activated protein kinase cascadesp53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascadesHeparin-binding EGF-like growth factor and ErbB signaling is essential for heart functionErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migrationTumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyGeneration and characterization of conditional heparin-binding EGF-like growth factor knockout mice.The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer.Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases.HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.Milk epidermal growth factor and gut protection.Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy.The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages.The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.Role of growth factors and their receptors in gastric ulcer healing.Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy.A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGFErbB signaling in cardiac development and disease.Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
P2860
Q22009058-3668E71D-F296-4C1F-BB03-F20FDB98104EQ22009917-ED76B728-58CB-4E3F-9262-0C1D727A163CQ22253346-27D7E5E2-FE46-4B35-94D5-F7094FE010CFQ24308695-FE6AF8C9-80BE-4403-9EF3-3B473EF4D274Q24319261-18E01FF0-1458-4F86-8784-7E3BE666FD91Q24337116-DF03423C-031F-4E54-8BD1-851A4A2CA533Q24532786-20C267F5-8D02-4736-ADB3-C882DD0456A2Q24534617-0B669926-AC35-4B7E-B12C-0D98E6D5B76EQ24535534-FFF7D213-76CC-4181-BD1E-335C0BF4CC4DQ24619754-0184FBEF-0A2B-4850-B23C-3AAD2C5F1AA8Q24684329-3BC4356D-ACB2-4A5E-AEAD-B544F8360152Q26852845-ADA54453-9974-4FFB-B9E8-EB4C286A609DQ26866067-B22D15EA-6D0F-4DBB-8B91-0C04107C8B69Q27300850-BCC53221-03E5-463A-857D-516D49CA0CCEQ27306884-AD1B7862-733E-4C9E-91F6-B8DD4E363DE0Q28269163-128260EC-67B8-4A39-91FD-3D27B96DF32AQ28285266-F99EB76A-B648-4CB8-B42E-F4BE089DFEFAQ28348018-A862CB68-D549-483F-A37C-62B0CC7E9786Q28362225-28536244-037A-4BFA-8654-8A249FEB56E1Q28505013-CC228C6C-3061-42B1-92FD-6A34DA1DC58DQ28578116-44D10A56-C895-4D57-8108-C0015A3D3074Q28609073-923E39DA-F15D-4F8E-89DD-76D5F9868F78Q28609160-7DC30B3A-107B-48FB-8DC8-7BCF035D65D8Q29040166-4E32BB99-3CD3-48A2-89EA-E7BEA3D5028FQ30485976-75940A2D-154D-490F-A6F6-1EDFEA921B15Q33538424-A4C0C592-5079-4667-9286-29D5986C61AAQ33700160-CED815B4-558A-47AB-8C72-690D2BB297CEQ33708436-D9E3C8ED-DF75-48A9-95D1-F6666E7AB4A5Q33781099-17062674-1231-4C94-8BB2-B993BBADA29CQ33781408-AB240A8D-5ABD-4EEC-8420-3E84B564DBA4Q33859549-B9A34154-3CF8-4D9A-8945-FC7CAF3DAD55Q33860043-DF1F970B-E0EF-4737-B1B1-9825BFAA1FEBQ33917661-BB29D2FB-28BC-4693-8A28-03CA31C4F19FQ33968565-8C02DDF9-F87D-489D-8FB2-234D16F3D56AQ34263687-FCBFC034-6FAB-482B-A3B2-8AB690AA0D74Q34516136-4821B563-3DEA-40A6-9B1D-45D7CF1EC026Q34517448-F6D295E7-842C-474E-92A2-B8B9B2A74E01Q34545577-135B1189-750E-49EB-9F92-71C78A56043EQ34563226-2E6EF65E-9C7F-4A1D-BEBE-DDB0973147F7Q34634264-67530647-3700-456E-A4A4-590BEAED3810
P2860
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@ast
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en-gb
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@nl
type
label
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@ast
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en-gb
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@nl
prefLabel
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@ast
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en-gb
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Activation of HER4 by heparin- ...... emotaxis but not proliferation
@en
P2093
P2860
P304
P3181
P356
10.1093/EMBOJ/16.6.1268
P407
P577
1997-03-17T00:00:00Z